Myelodysplastic neoplasm with increased blasts

What it is

From: Orphanet

Refractory anemia with excess blasts (RAEB) is a frequent severe subtype of myelodysplastic syndrome (MDS) characterized by cytopenias with unilineage or multilineage dysplasia and 5% to 19% blasts in bone marrow or blood.

Reported clinical features and what the terms mean

The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.

The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.

Anemia of inadequate production · Very frequent (99-80%)

A kind of anemia characterized by inadequate production of erythrocytes.

Fatigue · Very frequent (99-80%)

A subjective feeling of tiredness characterized by a lack of energy and motivation.

Anemic pallor · Frequent (79-30%)

A type of pallor that is secondary to the presence of anemia.

Exertional dyspnea · Frequent (79-30%)

Perceived difficulty to breathe that occurs with exercise or exertion and improves with rest.

Fever · Frequent (79-30%)

Body temperature elevated above the normal range.

Palpitations · Frequent (79-30%)

A sensation that the heart is pounding or racing, which is a non-specific sign but may be a manifestation of arrhythmia.

Abnormal albumin level · Occasional (29-5%)

Any deviation from the normal concentration of albumin in the blood circulation.

Abnormal bleeding · Occasional (29-5%)

An abnormal susceptibility to bleeding, often referred to as a bleeding diathesis. A bleeding diathesis may be related to vascular, platelet and coagulation defects.

Abnormal circulating protein level · Occasional (29-5%)

An abnormal level of a circulating protein in the blood.

Abnormal mean corpuscular volume · Occasional (29-5%)

A deviation from normal of the mean corpuscular volume, or mean cell volume (MCV) of red blood cells, usually taken to be 80 to 100 femtoliters.

Abnormality of bone marrow cell morphology · Occasional (29-5%)

An anomaly of the form or number of cells in the bone marrow.

Acute myeloid leukemia · Occasional (29-5%)

A form of leukemia characterized by overproduction of an early myeloid cell.

Bone marrow hypocellularity · Occasional (29-5%)

A reduced number of hematopoietic cells present in the bone marrow relative to marrow fat.

Bone pain · Occasional (29-5%)

An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) localized to bone.

Other findings in the same source

From: Orphanet

Additional reported features include Chronic infection (Occasional (29-5%)); Increased total leukocyte count (Occasional (29-5%)); Multiple lineage myelodysplasia (Occasional (29-5%)); Pedal edema (Occasional (29-5%)); Retinal hemorrhage (Occasional (29-5%)); Single lineage myelodysplasia (Occasional (29-5%)); Thrombocytopenia (Occasional (29-5%)); Dysplastic granulopoesis (Occasional (29-5%)). This is a selected summary, not a complete description of the condition.

When it may begin

From: Orphanet

Adult

Inheritance in the source

From: Orphanet

Not applicable

Frequency and the population described

From: Orphanet

Annual incidence: 1-9 / 1 000 000; Europe; Value and class.

Which doctor should you see?

The suggested department for discussing Myelodysplastic neoplasm with increased blasts is Oncology, with a oncologist and relevant organ specialist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.

Additional services that may be relevant, depending on the findings, include: Relevant organ specialist / Surgical Oncology as indicated.

This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.

How to prepare for an assessment

Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.

Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.

• Has the exact tumour type been confirmed, and is staging relevant?
• What is the goal of each proposed treatment option?
• How will side effects, daily function and supportive care be addressed?

Treatment discussions and follow-up

The material gathered for this draft does not provide a complete condition-specific treatment pathway for Myelodysplastic neoplasm with increased blasts. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.

Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.

The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.

When to seek emergency help

Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.